Regent Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-20,280
| Closed | -$589K | – | 205 |
|
|
2020
Q4 | $589K | Sell |
20,280
-16,699
| -45% | -$485K | 0.16% | 114 |
|
|
2020
Q3 | $1.04M | Sell |
36,979
-2,600
| -7% | -$73.3K | 0.32% | 78 |
|
|
2020
Q2 | $1.28M | Sell |
39,579
-1,000
| -2% | -$32.3K | 0.43% | 60 |
|
|
2020
Q1 | $1.65M | Sell |
40,579
-750
| -2% | -$30.6K | 0.68% | 41 |
|
|
2019
Q4 | $2.55M | Buy |
41,329
+1,670
| +4% | +$103K | 0.78% | 35 |
|
|
2019
Q3 | $2.89M | Buy |
39,659
+650
| +2% | +$47.4K | 0.95% | 29 |
|
|
2019
Q2 | $3.21M | Sell |
39,009
-4,030
| -9% | -$331K | 1.04% | 26 |
|
|
2019
Q1 | $3.04M | Sell |
43,039
-4,300
| -9% | -$303K | 1.01% | 25 |
|
|
2018
Q4 | $2.13M | Buy |
47,339
+900
| +2% | +$40.5K | 0.8% | 38 |
|
|
2018
Q3 | $2.63M | Buy |
46,439
+6,675
| +17% | +$377K | 0.82% | 34 |
|
|
2018
Q2 | $2.66M | Buy |
39,764
+3,799
| +11% | +$254K | 0.89% | 33 |
|
|
2018
Q1 | $2.09M | Buy |
35,965
+2,965
| +9% | +$173K | 0.71% | 44 |
|
|
2017
Q4 | $2.13M | Buy |
33,000
+5,550
| +20% | +$358K | 0.7% | 43 |
|
|
2017
Q3 | $1.44M | Buy |
+27,450
| New | +$1.44M | 0.49% | 64 |
|